AMPHIPROTECH Trademark

Trademark Overview


On Wednesday, November 30, 2022, a trademark application was filed for AMPHIPROTECH with the United States Patent and Trademark Office. The USPTO has given the AMPHIPROTECH trademark a serial number of 79360545. The federal status of this trademark filing is REGISTERED as of Tuesday, March 5, 2024. This trademark is owned by Shanghai Puyou Biomedical Co., Ltd.. The AMPHIPROTECH trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer and antibiotics; Medicines for human purposes for the prevention and treatment of liver diseases; Medicines for human purposes for the prevention and treatment of respiratory system disorders; Medicines for human purposes for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Medicines for human purposes for the prevention and treatment of gastro-intestinal diseases; Medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; Medicines for human purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Chemical preparations for pharmaceutical purposes for the treatment of infectious diseases, blood disorders, immune system related diseases, tumours, thyroid disease, cardiovas...
amphiprotech

General Information


Serial Number79360545
Word MarkAMPHIPROTECH
Filing DateWednesday, November 30, 2022
Status700 - REGISTERED
Status DateTuesday, March 5, 2024
Registration Number7318395
Registration DateTuesday, March 5, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 19, 2023

Trademark Statements


Goods and ServicesMedicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer and antibiotics; Medicines for human purposes for the prevention and treatment of liver diseases; Medicines for human purposes for the prevention and treatment of respiratory system disorders; Medicines for human purposes for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Medicines for human purposes for the prevention and treatment of gastro-intestinal diseases; Medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; Medicines for human purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Chemical preparations for pharmaceutical purposes for the treatment of infectious diseases, blood disorders, immune system related diseases, tumours, thyroid disease, cardiovascular and cerebrovascular diseases, inflammation and cancer; Biological preparations for medical purposes for the treatment of cancer, insomnia and heart disease; Biological preparations for medical purposes for the prevention and treatment of liver diseases; Biological preparations for medical purposes for the prevention and treatment of respiratory system disorders; Biological preparations for medical purposes for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Biological preparations for medical purposes for the prevention and treatment of gastro-intestinal diseases; Biological preparations for medical purposes for the prevention and treatment of immune system related diseases and disorders; Biological preparations for medical purposes for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Drugs, namely, insulin for the treatment of diabetes for medical purposes; Pharmaceutical preparations, namely, analgesics, antibiotics and aspirin; Pharmaceutical preparations for the prevention and treatment of liver diseases; Pharmaceutical preparations for the prevention and treatment of respiratory system disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Pharmaceutical preparations for the prevention and treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Medicines in form of tablet form for the treatment of cancer, insomnia and heart disease; Medicines in form of tablet form for the prevention and treatment of liver diseases; Medicines in form of tablet form for the prevention and treatment of respiratory system disorders; Medicines in form of tablet form for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Medicines in form of tablet form for the prevention and treatment of gastro-intestinal diseases; Medicines in form of tablet form for the prevention and treatment of immune system related diseases and disorders; Medicines in form of tablet form for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Biochemical medicines for the treatment of cancer, insomnia and heart disease; Biochemical medicines for the prevention and treatment of liver diseases; Biochemical medicines for the prevention and treatment of respiratory system disorders; Biochemical medicines for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases and diabetes; Biochemical medicines for the prevention and treatment of gastro-intestinal diseases; Biochemical medicines for the prevention and treatment of immune system related diseases and disorders; Biochemical medicines for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Capsules for medicines for the treatment of cancer, insomnia and heart disease; Capsules for medicines for the prevention and treatment of liver diseases; Capsules for medicines for the prevention and treatment of respiratory system disorders; Capsules for medicines for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases, diabetes; Capsules for medicines for the prevention and treatment of gastro-intestinal diseases; Capsules for medicines for the prevention and treatment of immune system related diseases and disorders; Capsules for medicines for the prevention and treatment of viral and infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cancer, tumors and cognitive disorders; Injectable medicinal solutions, namely, dermal fillers; Injectable medicinal solutions, namely, injectable contraceptives; Dietetic foods and beverages adapted for medical use; Dietetic preparations adapted for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 20, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameShanghai Puyou Biomedical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCN

Party NameShanghai Puyou Biomedical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCN

Party NameShanghai Puyou Biomedical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Saturday, September 9, 2023ASSIGNED TO EXAMINER
Thursday, January 19, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 24, 2023APPLICATION FILING RECEIPT MAILED
Friday, September 15, 2023NON-FINAL ACTION WRITTEN
Saturday, September 16, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 28, 2023REFUSAL PROCESSED BY MPU
Thursday, September 28, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 17, 2023REFUSAL PROCESSED BY IB
Thursday, November 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 9, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 29, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 29, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, December 19, 2023NOTIFICATION PROCESSED BY IB
Tuesday, December 19, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 5, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, March 5, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, June 6, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, June 6, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, June 6, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED